Journal Information
Vol. 46. Issue S4.
EPOC: de la etiopatogenia al tratamiento
Pages 16-21 (September 2010)
Share
Share
Download PDF
More article options
Vol. 46. Issue S4.
EPOC: de la etiopatogenia al tratamiento
Pages 16-21 (September 2010)
Full text access
EPOC en individuos no fumadores
COPD in nonsmokers
Visits
...
Myriam Calle Rubio
Corresponding author
med010161@saludalia.com

Autor para correspondencia.
, Juan Luis Rodríguez Hermosa, José Luis Álvarez-Sala Walther
Servicio de Neumología, Hospital Clínico San Carlos, Universidad Complutense, Madrid, España
Article information
Abstract
Bibliography
Download PDF
Statistics
Resumen

La asociación de la enfermedad pulmonar obstructiva crónica (EPOC) con el tabaco está ampliamente demostrada. Sin embargo, cada vez hay más estudios que ponen de manifiesto la no desdeñable prevalencia de la EPOC entre los individuos no fumadores. Por tanto, existen otros factores, endógenos y exógenos, que pueden influir en que un sujeto llegue o no a presentar la enfermedad. En el presente artículo se revisa la posible contribución genética, la influencia del sexo o de otras enfermedades respiratorias (como el asma crónica o la tuberculosis), así como la contaminación ambiental o la exposición laboral, al desarrollo final de la EPOC.

Palabras clave:
Enfermedad pulmonar obstructiva crónica
No fumadores
Exposición laboral
Contaminación ambiental
Abstract

The association of chronic obstructive pulmonary disease (COPD) and smoking is well established. However, an increasing number of studies have reported a not inconsiderable prevalence of COPD among nonsmokers. Therefore, other factors, both endogenous and exogenous, may influence the development of this disease. The present article reviews the influence of possible genetic factors, gender and other respiratory diseases (such as chronic asthma and tuberculosis), as well as environmental pollution and occupational exposure in the development of COPD.

Keywords:
Chronic obstructive pulmonary disease
Nonsmokers
Occupational exposure
Environmental pollution
Full text is only aviable in PDF
Bibliografía
[1.]
Global Initiative for Chronic Obstructive Lung Disease Executive summary: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. [Accedido May de 2010]. Updated diciembre 2009. Disponible en: www.goldcopd.com
[2.]
Peces-Barba G, Barberá JA, Agustí A, Casanova C, Casas A, Izquierdo JL, et al. Guía de práctica clínica de diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica SEPAR-ALAT, 2009. [Accedido Feb de 2010]. Disponible en: www.separ.es
[3.]
J.L. Alvarez-Sala, E. Cimas, J.F. Masa, M. Miravitlles, J. Molina, K. Naberan, et al.
Recomendaciones para la atención al paciente con enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 37 (2001), pp. 269-278
[4.]
P. Shirtcliffe, M. Weatherall, S. Marsh, J. Travers, A. Hansell, A. McNaughton, et al.
COPD prevalence in a random population survey: a matter of definition.
Eur Respir J, 30 (2007), pp. 232-239
[5.]
S. Liu, Y. Zhou, X. Wang, D. Wang, J. Lu, J. Zheng, et al.
Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China.
Thorax, 62 (2007), pp. 889-897
[6.]
Y. Zhou, C. Wang, W. Yao, P. Chen, J. Kang, S. Huang, et al.
COPD in Chinese nonsmokers.
Eur Respir J, 33 (2009), pp. 509-518
[7.]
A. Caballero, C.A. Torres-Duque, C. Jaramillo, F. Bolívar, F. Sanabria, P. Osorio, et al.
Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study).
Chest, 133 (2008), pp. 343-349
[8.]
A.M. Menezes, R. Pérez-Padilla, J.R. Jardim, A. Muiño, M.V. Lopez, G. Valdivia, et al.
Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study.
Lancet, 366 (2005), pp. 1875-1881
[9.]
H. Gunen, S.S. Hacievliyagil, O. Yetkin, G. Gulbas, L.C. Mutlu, E. Pehlivan.
Prevalence of COPD: first epidemiological study of a large region in Turkey.
Eur J Intern Med, 19 (2008), pp. 499-504
[10.]
D.S. Kim, Y.S. Kim, K.S. Jung, J.H. Chang, C.M. Lim, J.H. Lee, et al.
Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey.
Am J Respir Crit Care Med, 172 (2005), pp. 842-847
[11.]
A. Lindberg, A.C. Jonsson, E. Rönmark, R. Lundgren, L.G. Larsson, B. Lundbäck.
Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits.
Respiration, 72 (2005), pp. 471-479
[12.]
G. Viegi, M. Pedreschi, F. Pistelli, F. Di Pede, S. Baldacci, L. Carrozzi, et al.
Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition.
Chest, 117 (2000), pp. 339S-345S
[13.]
V.S. Peña, M. Miravitlles, R. Gabriel, C.A. Jiménez-Ruiz, C. Villasante, J.F. Masa, et al.
Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study.
Chest, 118 (2000), pp. 981-989
[14.]
J. Ancochea, C. Badiola, E. Duran-Tauleria, F. Garcia Rio, M. Miravitlles, L. Muñoz, et al.
Estudio EPI-SCAN: resumen del protocolo de un estudio para estimar la prevalencia de EPOC en personas de 40 a 80 años en España.
Arch Bronconeumol, 45 (2009), pp. 41-47
[15.]
C.E. Behrendt.
Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles.
Chest, 128 (2005), pp. 1239-1244
[16.]
A.S. Buist, W.M. Vollmer, M.A. McBurnie.
Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative.
Int J Tuberc Lung Dis, 12 (2008), pp. 703-708
[17.]
S.S. Salvi, P.J. Barnes.
Chronic obstructive pulmonary disease in non-smokers.
[18.]
B. Lundbäck, A. Lindberg, M. Lindström, E. Rönmark, A.C. Jonsson, E. Jönsson, et al.
Not 15 but 50% of smokers develop COPD? -Report from the Obstructive Lung Disease in Northern Sweden Studies.
Respir Med, 97 (2003), pp. 115-122
[19.]
A. Ramírez-Venegas, R.H. Sansores, R. Pérez-Padilla, J. Regalado, A. Velázquez, C. Sánchez, et al.
Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco.
Am J Respir Crit Care Med, 173 (2006), pp. 393-397
[20.]
R.M. Shavelle, D.R. Paculdo, S.J. Kush, D.M. Mannino, D.J. Strauss.
Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III follow-up study.
Int J Chron Obstruct Pulmon Dis, 4 (2009), pp. 137-148
[21.]
O. Moran-Mendoza, J.R. Pérez-Padilla, M. Salazar-Flores, F. Vázquez-Alfaro.
Wood smoke-associated lung disease: a clinical, functional, radiological and pathological description.
Int J Tuberc Lung Dis, 12 (2008), pp. 1092-1098
[22.]
O. Joost, J.B. Wilk, L.A. Cupples, M. Harmon, A.M. Shearman, C.T. Baldwin, et al.
Genetic loci influencing lung function: a genome-wide scan in the Framingham Study.
Am J Respir Crit Care Med, 165 (2002), pp. 795-799
[23.]
L. Joos, P.D. Paré, A.J. Sandford.
Genetic risk factors of chronic obstructive pulmonary disease.
Swiss Med Wkly, 132 (2002), pp. 27-37
[24.]
S.C. McCloskey, B.D. Patel, S.J. Hinchliffe, E.D. Reid, N.J. Wareham, D.A. Lomas.
Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction.
Am J Respir Crit Care Med, 164 (2001), pp. 1419-1424
[25.]
E.K. Silverman, L.J. Palmer, J.D. Mosley, M. Barth, J.M. Senter, A. Brown, et al.
Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease.
Am J Hum Genet, 70 (2002), pp. 1229-1239
[26.]
R. Vidal, I. Blanco, F. Casas, R. Jardí, M. Miravitlles.
Diagnóstico y tratamiento del déficit de alfa-1-antitripsina.
Arch Bronconeumol, 42 (2006), pp. 645-659
[27.]
A.J. Sandford, T. Chagani, T.D. Weir, J.E. Connett, N.R. Anthonisen, P.D. Paré.
Susceptibility genes for rapid decline of lung function in the lung health study.
Am J Respir Crit Care Med, 163 (2001), pp. 469-473
[28.]
K. Hirano, T. Sakamoto, Y. Uchida, Y. Morishima, K. Masuyama, Y. Ishii, et al.
Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease.
Eur Respir J, 18 (2001), pp. 748-752
[29.]
J.B. Soriano, W.C. Maier, P. Egger, G. Visick, B. Thakrar, J. Sykes, et al.
Recent trends in physician diagnosed COPD in women and men in the UK.
Thorax, 55 (2000), pp. 789-794
[30.]
C. Fletcher, R. Peto.
The natural history of chronic airflow obstruction.
Br Med J, 1 (1977), pp. 1645-1648
[31.]
J.M. Antó, P. Vermeire, J. Vestbo, J. Sunyer.
Epidemiology of chronic obstructive pulmonary disease.
Eur Respir J, 17 (2001), pp. 982-994
[32.]
G. Viegi, A. Scognamiglio, S. Baldacci, F. Pistelli, L. Carrozzi.
Epidemiology of chronic obstructive pulmonary disease (COPD).
Respiration, 68 (2001), pp. 4-19
[33.]
A.S. Fairbairn, D.D. Reid.
Air pollution and other local factors in respiratory disease.
Br J Prev Soc Med, 12 (1958), pp. 94-103
[34.]
U. Ackermann-Liebrich, P. Leuenberger, J. Schwartz, C. Schindler, C. Monn, G. Bolognini, et al.
Lung function and long term exposure to air pollutants in Switzerland.
Am J Respir Crit Care Med, 155 (1997), pp. 122-129
[35.]
R. Doll, R. Peto, J. Boreham, I. Sutherland.
Mortality in relation to smoking: 50 years’ observations on male British doctors.
[36.]
A.D. Lopez, C.D. Mathers, M. Ezzati, D.T. Jamison, C.J. Murray.
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.
Lancet, 367 (2006), pp. 1747-1757
[37.]
A. Sood, H. Petersen, C. Blanchette, P. Meek, S. Belinsky, M. Picchi, et al.
Wood smoke-associated chronic obstructive pulmonary disease (COPD) –Underappreciated in the United States?.
Am J Respir Crit Care Med, 179 (2009), pp. A4742
[38.]
J.Y. Po, N. Shahidi, J.M. FitzGerald, C. Carlsten.
Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis.
Am J Respir Crit Care Med, 179 (2009), pp. A4740
[39.]
R.J. Hancox, R. Poulton, J.M. Greene, C.R. McLachlan, M.S. Pearce, M.R. Sears.
Associations between birth weight, early childhood weight gain and adult lung function.
Thorax, 64 (2009), pp. 228-232
[40.]
J. Balmes, M. Becklake, P. Blanc, P. Henneberger, K. Kreiss, C. Mapp, et al.
Environmental and Occupational Health Assembly. American Thoracic SocietyAmerican Thoracic Society statement: occupational contribution to the burden of airway disease.
Am J Respir Crit Care Med, 167 (2003), pp. 787-797
[41.]
P. Vineis, L. Airoldi, F. Veglia, L. Olgiati, R. Pastorelli, H. Autrup, et al.
Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study.
[42.]
B. Lamprecht, L. Schirnhofer, B. Kaiser, M. Studnicka, A.S. Buist.
Farming and the prevalence of non-reversible airways obstruction: results from a population-based study.
Am J Ind Med, 50 (2007), pp. 421-426
[43.]
W. Eduard, N. Pearce, J. Douwes.
Chronic bronchitis, COPD, and lung function in farmers: the role of biological agents.
Chest, 136 (2009), pp. 716-725
[44.]
S. Weinmann, W.M. Vollmer, V. Breen, M. Heumann, E. Hnizdo, J. Villnave, et al.
COPD and occupational exposures: a case-control study.
J Occup Environ Med, 50 (2008), pp. 561-569
[45.]
M.J. Hegewald, R.O. Crapo.
Socioeconomic status and lung function.
Chest, 132 (2007), pp. 1608-1614
Copyright © 2010. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología

Subscribe to our newsletter

Article options
Tools

Are you a health professional able to prescribe or dispense drugs?